PRMEPrime Medicine, Inc.
$3.58-39% 1Y
$3.58
$2.7052 weeks$6.45
The financials
Prime Medicine, Inc. by the numbers
For the full year FY2025, revenue was $4.6M (+55% year on year) and net income −$201M. The next results filing is expected around Nov 6, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | n/a | $1.1M | n/a |
| Operating income | −$43M | −$53M | n/a |
| Net income | −$42M | −$53M | n/a |
| Diluted EPS | −$0.24 | −$0.41 | n/a |